Pharmacogenomics: Ethical and Regulatory Issues

Matthew Decamp, Allen Buchanan

Research output: Chapter in Book/Report/Conference proceedingChapter

2 Scopus citations


While acknowledging the potential benefits of pharmacogenomics as a methodology, a number of comprehensive reports in the past several years examine a multitude of ethical, legal, and social factors that may limit the extent to which these benefits are realized - and realized in ethically acceptable ways. This article aims to identify and explore the most basic ethical and regulatory issues that are likely to arise if pharmacogenomics becomes widely enough used to have a significant impact on research and clinical practice. First, however, it addresses the question of whether pharmacogenomic tests are unique when compared to other genetic tests and thus deserving of more or less stringent ethical and regulatory requirements.

Original languageEnglish (US)
Title of host publicationThe Oxford Handbook of Bioethics
PublisherOxford University Press
ISBN (Electronic)9780191577475
ISBN (Print)9780199562411
StatePublished - Sep 2 2009
Externally publishedYes


  • Clinical practice
  • Ethical requirements
  • Genetic tests
  • Pharmacogenomic tests
  • Pharmacogenomics
  • Social factors

ASJC Scopus subject areas

  • General Arts and Humanities


Dive into the research topics of 'Pharmacogenomics: Ethical and Regulatory Issues'. Together they form a unique fingerprint.

Cite this